Morganella Morganii Infection in Hirudo Medicinalis (Iran): A Case Report
Case report published in Veterinary sciences (2022)
Abstract
Medicinal leeches (Hirudo medicinalis) are used in surgical and non-surgical manners. Morganella morganii is an opportunistic and zoonotic pathogenic bacterium causing serious clinical complications. In this study, we isolated, discovered and characterized M. morganii-infected H. medicinalis. We detected and identified M. morganii in all inflamed and swollen Hirudo medicinalis samples. The 16S rRNA sequence of the isolates confirmed all strains of M. morganii. All strains were sensitive to Ceftriaxone, Ceftiofur, Danofloxacin, Ciprofloxacin, Enrofloxacin, Oxytetracycline, and Meropenem and were resistant to Erythromycin, Amoxicillin, Ampicillin, Cefazolin, Colistin, Penicillin G, and Lincomycin. This pathogenic bacterium is a zoonotic pathogen, and monitoring the prevalence rate of this bacteria is strongly necessary for leeches used in human medical treatment and care. Finally, all infected leeches were treated successfully in this case report study.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Summary
This case report isolates Morganella morganii from inflamed Hirudo medicinalis in Iran, confirms identity by 16S rRNA sequencing, and reports susceptibility to antibiotics including ciprofloxacin and enrofloxacin but resistance to erythromycin, amoxicillin, penicillin G, and colistin.
Why This Matters for Hirudotherapy
This report examined the isolation and characterization of Morganella morganii — an opportunistic, zoonotic pathogenic bacterium — from inflamed and swollen medicinal leech (Hirudo medicinalis) specimens, including 16S rRNA confirmation and antibiotic susceptibility profiling of the isolates. M. morganii can cause serious clinical complications, and the reported resistance profile (resistant to ampicillin, penicillin G, amoxicillin, and others; sensitive to ciprofloxacin, meropenem, and several additional agents) informs microbial safety considerations for leeches used in human medical treatment. The authors emphasize that monitoring prevalence of this pathogen in therapeutic leeches is necessary, and note that all infected leeches were treated successfully. This is a case report providing no quantitative prevalence data, no human clinical outcome data, and no broader surveillance.
Citation
Reference (Vancouver style)
Rahmati Holasoo H, Tamai IA, Brück WM, Pakbin B, Nasiri A, Azizi A. Morganella Morganii Infection in Hirudo Medicinalis (Iran): A Case Report. Vet Sci. 2022;9(10):562. doi:10.3390/vetsci9100562. PMID: 36288175
Bibliographic details (authors, volume, pages, DOI) are taken from the PubMed record.
Added to ASH library: March 18, 2026 · Site last updated: November 1, 2026